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.2012.12.Abstract Epinephrine is the recommended treatment in anaphylactic shock. Recently cases of ana-
phylactic shock refractory to epinephrine have been reported. The authors report the efﬁcacy of a
bolus of vasopressin in a refractory anaphylactic shock caused by rocuronium after failure the epi-
nephrine. Thought this case report and review of literature, the authors discuss the mechanism of
action and the effectiveness of this alternative treatment, vasopressin, in refractory anaphylactic
shock to epinephrine.
ª 2013 Egyptian Society of Anesthesiologists. Production and hosting by Elsevier B.V.
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Anaphylaxis is a severe life-threatening generalized or systemic
hypersensitivity reaction [1]. The incidence of anaphylactic
reactions during anesthesia was variable [2,3]. Epinephrine is
considered as the ﬁrst line of treatment. However, clinical cases
of resistance to epinephrine treatment have been reported. In
these situations, management is variable and no codiﬁed.
The use of different therapeutic alternatives to epinephrine
seems justiﬁed given the risk of serious complications inst Box 8840, Rabat, Agdal
77.
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002uncontrolled anaphylactic shock. We describe a case in which
a bolus of vasopressin established hemodynamic stability in
anaphylactic shock caused by rocuronium after failure of ﬂuid
therapy and epinephrine.
2. Case report
A42-year-old female, weighing 74 kg, was scheduled for elective
laparoscopic surgery of gallbladder. Her past history included a
diabetes mellitus stabilized by diet alone and arterial hyperten-
sion treated with amlodipin, but had no personal or family his-
tory of allergy. Preoperative evaluation noted a weight of 74 kg,
height 169 cm with a body mass index of 25.91 kg/m2. Her
blood pressure was 143/81 mm Hg, heart rate was 76 beats/
min, oxygen saturation was 99% in ambient air and tempera-
ture at 37.3 C. Cardiovascular exam noted a dyspnea grade I
of New York Heart Association classiﬁcation (NYHA) without
angina, with ametabolic equivalent (MET) > 4METs. Electro-
cardiogram noted a left ventricular hypertrophy without con-
duction or rhythm disorders. The echocardiography showed aosting by Elsevier B.V. Open access under CC BY-NC-ND license.
176 M. Bensghir et al.moderate disorder of left ventricular relaxation, a normal global
and segmental contractility without valvular or pericardial
disease. Ejection fraction was estimated to 71%. Exam and
chest-X-ray were unremarkable. Laboratory tests noted blood
glucose at 130 mg/dL, urea plasma at 34 mg/dL, creatinine at
1.2 mg/dL and C-reactive protein (CRP) at 5 lg/mL, hemoglo-
bin concentration at 13gm/dL and platelet count at 231,000/
mm3. Instructions during the pre anesthetic visit consist of a pre-
operative fasting of six hours with a premedication orally
hydroxysine (75 mg). In the operating room a standard moni-
toring was installed (Zeus Inﬁnity Empowered Dra¨ger Medical
AG &CO.KG Lu¨beck Germany). Non invasive blood pressure
(BP) was 145/65 mmHg, heart rate (HR) was 69 beats/min and
her oxygen saturation (SPO2) was 98%. Venous access was se-
cured with an 18 gauge cannula. After a ﬂuid resuscitation with
300 ml of saline solution (0.9%) and preoxygenation (expired
fraction of oxygen > 92%), general anesthesia was induced
using midazolam (2 mg), fentanyl (250 lg), etomidate (18 mg),
lidocaine 2% (80 mg). Rocuronium (35 mg) was administered
after efﬁcient mask ventilation. Three minutes later, the trachea
was intubated with a single tube of 7 mm in diameter without
problems. The patient was connected to the anesthesia machine,
(Zeus Inﬁnity Empowered Dra¨ger Medical AG &CO.KG
Lu¨beck Germany), with a tidal volume of 550 ml and a respira-
tory rate of 14 cycles/min. General anesthesia was continued
with isoﬂurane (1–1.3%) in a mixture of nitrous oxide (50%)
and oxygen (50%). Continuousmonitoring included electrocar-
diography (ECG), pulse oximetry (SpO2), non invasive blood
pressure (BP) and capnography [endtidal carbon dioxide
(EtCO2)]. Within minutes of anesthetic induction, the patient
developed severe hypotension (67/32 mm Hg) associated with
sinus-tachycardia at rates varying between 145–157 beats/min.
Hypotension related to induction of anesthesia was suspected.
Isoﬂurane and nitrous oxide were stopped and 100% inspired
oxygen was started. Intravenous rapid infusion of crystalloids
was started with a bolus of ephedrine and operating table was
placed in Trendelenburg position. Pulmonary auscultation re-
vealed clear breaths sounds and no wheezing. Peak airway pres-
sure (PAwP) was normal and remained unchanged (21–22 cm
H2O). There were no changes in pulse oximetry (99–98%), cap-
nography (36–38 mmHg) and nasopharyngeal temperature was
normal (36.5 C). A total of 2500 ml of crystalloids, 30 mg of
ephedrine and 5 mg of epinephrine was administered without
success. Provisional diagnosis of distributive shock caused by
anaphylaxis was made. The internal jugular central venous
catheter and femoral arterial catheter were placed. Infusion of
epinephrine was started at 0.03 lg/kg/min and increase to
0.5 lg/kg/min. The patient’s conditions remained unchanged
(blood pressure at 71/39 mm Hg, sinus-tachycardia at
149 beats/min). The addition of dobutamine did not allow any
hemodynamic improvement. After failure of these means and
increasing dose of vasopressor support, an injection a bolus of
2UI vasopressin was decided.Within 5 min, the patient was sta-
bilized with a blood pressure 114/52 mm Hg and heart rate 89
beats/min. The surgery was cancelled. The vasopressor drugs
were continued. The patient was transferred to intensive care
unit with a propofol infusion. A bolus of dexamethasone
(8 mg) was administrated. The vasopressor infusions were grad-
ually withdrawn over three hours. One hour later the patient
was extubated without problems. She was discharged home
on day 2. Six weeks later, during follow-up skin allergy testing
for rocuronium was positive at dilution 1/100. Skin testing forall the administered drugs including latex and others muscle
relaxant was negative. Twomonths later, the patient underwent
the primary scheduled surgery under general anesthesia using
isoﬂurane, fentanyl and vecuronium. The anesthetic course
was unremarkable.3. Discussion
Anaphylaxis is a severe life-threatening generalized or systemic
hypersensitivity reaction [1]. Its’ occurrence during anesthesia
is uncommon. The true incidence of this complication is difﬁ-
cult to determine due to uncertainties over the completeness of
the data. The estimated overall frequency has been reported to
vary between 1 in 5000 and 1 in 20,000 procedures [2,3]. The
mortality from these reactions is in the range from 3% to
6%, and an additional 2% of patients experience signiﬁcant
residual brain damage [4]. All the anesthetic drugs may be
implicated in the anaphylactic reactions. It is difﬁcult to iden-
tify the responsible agent because a large number of drugs have
been administered to the patient in most cases such antibiotic,
opioids, and neuromuscular blocking agents (NMBAs). A fol-
low-up investigation must be made to determine the responsi-
ble agent. We describe a case in which a bolus of vasopressin
established hemodynamic stability in a refractory anaphylactic
shock to catecholamine’s caused by rocuronium. Various etiol-
ogies can explain a cardiovascular collapse during anesthesia
such a myocardial infarction, a septic shock or anaphylaxis.
The absence of fever in our patient and the rapidly hemody-
namic degradation were not in favor of the diagnosis of the
septic shock. In the same way, the absence of modiﬁcation
of electrocardiogram and normal level of troponin were not
in favor of cardiogenic shock. Any ventricular kinetics disor-
ders have not reveled in intensive care unit by echocardiogra-
phy. Our patient has received midazolam, fentanyl, lidocaine,
isoﬂurane and rocuronium. A severe hemodynamic instability
during the use of isoﬂurane in a patient with idiopathic scoli-
osis was reported; the suspected mechanism was anaphylaxis
reaction or uncommon cardiovascular sensitivity to isoﬂurane
[5]. The incidence of anaphylactic reactions to fentanyl, lido-
caine and midazolam is very low [6,7]. In our case, patient
was stabilized with isoﬂurane and a bolus of fentanyl was given
without problems. The prophylactic antibiotic was not given
yet.
The rocuronium was highly suspected because of high inci-
dence of allergy to NMBAs. The incidence of anaphylactic
reactions to NMBAs differs between countries (1/5000–1/
150,000) [6,7,2]. Responsibility of pholcodine in these reactions
is suspected [8]. This variability in the incidence of anaphylac-
tic reactions between countries could be explained by the var-
iability in consumption of pholcodine them [9]. These agents
can induce two types of reactions. One is driven by an immu-
nological mechanism and is IgE-dependent and second one re-
sult from nonspeciﬁc stimulation of mast cells [10,11].
In anaphylactic shock, the symptomatology was predomi-
nant by cardiovascular collapse and arrhythmia, respiratory
symptoms are slightly less common, but may predominant in
patients with pr-existing asthma, cutaneous symptoms are usu-
ally hidden by surgical drapings. In our case were noted only
cardiovascular collapse and tachycardia. Increases blood hista-
mine and tryptase concentrations conﬁrmed the diagnosis of
anaphylaxis reaction. Skin prick testing is the gold standard,
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have no documented elevation of histamine or tryptase be-
cause it is not available in our hospital; the skin test was posi-
tive conﬁrming the diagnosis of anaphylactic shock induced by
rocuronium.
The guidelines treatments of anaphylaxis reaction during
anesthesia include ﬂuids therapy and vasopressor. This treat-
ment was facilitated because the patient is usually monitored
and has intravenous access in operative room. All guidelines
recommend epinephrine for perioperative management of ana-
phylaxis [1,6,12–14]. However this recommendation was based
in experimental and clinical data [10]. Using the criteria
evidence-based medicine, epinephrine was classed Level C in
treatment of anaphylactic shock [15]. A clinical case with
resistance of epinephrine in this shock was reported. In some
cases of refractory anaphylactic shock; new pharmacologi-
cal approaches treatments have been described recently [16–
18].
Vasopressin, a nona-peptide, is synthesized as a large pro-
hormone in the paraventricular and supraoptic nuclei of the
hypothalamus. This agent is a direct systemic vasoconstrictor.
It is important for osmoregulation and maintenance of normo-
volemia [19]. Septic shock cause biphasic changes in its concen-
tration. In early shock, high concentration of vasopressin is
produced to maintain organ perfusion. As the shock state pro-
gresses, plasma vasopressin concentration decrease. The mech-
anism of this depletion was variable [20,21]. The use of
vasopressin in second phase of the septic shock, when the cat-
echolamine’s and ﬂuid were inefﬁcient, seems logical to make
up this deﬁcit. The pathophysiological mechanism of cardio-
vascular failure in anaphylactic shock is similar of septic
shock, including vasodilatation and hypovolemia resulting
from endothelial permeability. In severe anaphylactic shock,
refractory to epinephrine and ﬂuid, vasopressin can be used
is like in advanced septic shock. The efﬁcacy of this adminis-
tration in this situation was reported in some cases reports
[17,22–25]. The comparison between epinephrine and vaso-
pressin reveled that epinephrine was only partially effective
in reversing histamine-induced vasodilatation but vasopressin
was able to completely reverse histamine-induced vasodilata-
tion in an experimental study [26]. This advantage of vasopres-
sin in anaphylactic shock should be conﬁrmed by the futures
study. The optimum dose and the mode of delivery were var-
iable. A comparison of two doses of vasopressin in an experi-
mental study (0.08 vs 0.8 U/kg), the use a high dose (0.8 U/kg)
was associated with decreasing the survival rate [27]. In some
cases, vasopressin was administered by bolus (1 for 3), in an-
other, she was administered by bolus following by infusion.
Based on the experiences of authors, we decided, in our case,
to administer 2U (0.02 U/kg). The blood pressure had been
stabilized with this only bolus. Any infusion was necessary.
Vasopressin should be considered in second line after epineph-
rine, her administration early in a model of anaphylactic shock
induced a mortality of 100%, but administration of epineph-
rine followed by vasopressin has a rate of survival better
(100%) than to epinephrine alone (80%) [28].4. Conclusion
Through this case report and the review of the literature, we
can say that epinephrine remains the ﬁrst-line treatment ofthe anaphylactic shock, the vasopressin must be considered,
secondary, after failure of epinephrine.Acknowledgements
Special thanks to YD and YB for their help.
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